How much funding has Ginkgo Bioworks raised?

Ginkgo Bioworks has raised $790.0M in total funding, most recently a Extension Round.

Who are Ginkgo Bioworks's investors?

Ginkgo Bioworks's investors include Viking Global, Y Combinator Continuity Fund, General Atlantic, Felicis Ventures, Soaring Eagle Acquisition Corp, Cascade Investment.

When was Ginkgo Bioworks founded?

Ginkgo Bioworks was founded in 2009.

Where is Ginkgo Bioworks headquartered?

Ginkgo Bioworks is headquartered in Boston, Massachusetts, United States.

What industry is Ginkgo Bioworks in?

Ginkgo Bioworks operates in Automation, Diagnostics, Healthcare, Synthetic Biology.

How many employees does Ginkgo Bioworks have?

Ginkgo Bioworks has 501-1000 employees.

Ginkgo Bioworks

IPO

Our mission is to make biology easier to engineer.

Public · Boston, United States · Founded 2009 · $790.0M raised

YC S14

Headquarters: Boston, Massachusetts
Employees: 501–1000
Founded: 2009
Business Model: B2B
Website: ginkgobioworks.com

Total Funding: $790.0M
Last Round: $70.0M Extension RoundMay 2020
Rounds: 7
Type: Public

About

Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

Summary

Ginkgo Bioworks is an Automation company based in Boston, United States, founded in 2009. It has raised $790.0M in total across 7 rounds, most recently a $70.0M Extension Round round in May 2020. Investors include Viking Global, Y Combinator Continuity Fund and General Atlantic.

LinkedIn X (Twitter)GitHub